ES2756580T3 - Procedimiento para la preparación del compuesto N-(3,5-dimetilfenil)-N'-(2-trifluorometilfenil) guanidina - Google Patents
Procedimiento para la preparación del compuesto N-(3,5-dimetilfenil)-N'-(2-trifluorometilfenil) guanidina Download PDFInfo
- Publication number
- ES2756580T3 ES2756580T3 ES16756641T ES16756641T ES2756580T3 ES 2756580 T3 ES2756580 T3 ES 2756580T3 ES 16756641 T ES16756641 T ES 16756641T ES 16756641 T ES16756641 T ES 16756641T ES 2756580 T3 ES2756580 T3 ES 2756580T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- compound
- crystalline solid
- solid form
- dimethylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZFQMSPFLYBUSLE-UHFFFAOYSA-N Cc1cc(NC#N)cc(C)c1 Chemical compound Cc1cc(NC#N)cc(C)c1 ZFQMSPFLYBUSLE-UHFFFAOYSA-N 0.000 description 1
- DVIJFJSZZNOTLP-UHFFFAOYSA-N Cc1cc(NC(Nc2c(C(F)(F)F)cccc2)=N)cc(C)c1 Chemical compound Cc1cc(NC(Nc2c(C(F)(F)F)cccc2)=N)cc(C)c1 DVIJFJSZZNOTLP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/02—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of guanidine from cyanamide, calcium cyanamide or dicyandiamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/06—Purification or separation of guanidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP150102582A AR101498A1 (es) | 2015-08-11 | 2015-08-11 | Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a |
| EP15382424 | 2015-08-11 | ||
| PCT/EP2016/069033 WO2017025560A1 (en) | 2015-08-11 | 2016-08-10 | A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2756580T3 true ES2756580T3 (es) | 2020-04-27 |
Family
ID=56799434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16756641T Active ES2756580T3 (es) | 2015-08-11 | 2016-08-10 | Procedimiento para la preparación del compuesto N-(3,5-dimetilfenil)-N'-(2-trifluorometilfenil) guanidina |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10343984B2 (https=) |
| EP (1) | EP3334707B1 (https=) |
| JP (1) | JP6748188B2 (https=) |
| CN (1) | CN107922322B (https=) |
| AR (1) | AR101498A1 (https=) |
| BR (1) | BR112018002614B1 (https=) |
| CA (1) | CA2994781A1 (https=) |
| CY (1) | CY1122481T1 (https=) |
| DK (1) | DK3334707T3 (https=) |
| ES (1) | ES2756580T3 (https=) |
| HR (1) | HRP20192301T1 (https=) |
| HU (1) | HUE046959T2 (https=) |
| LT (1) | LT3334707T (https=) |
| MX (1) | MX383481B (https=) |
| PL (1) | PL3334707T3 (https=) |
| PT (1) | PT3334707T (https=) |
| RS (1) | RS59759B1 (https=) |
| RU (1) | RU2737430C2 (https=) |
| SI (1) | SI3334707T1 (https=) |
| SM (1) | SMT201900747T1 (https=) |
| WO (1) | WO2017025560A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN172842B (https=) * | 1990-05-17 | 1993-12-11 | Boots Pharmaceuticals Limited | |
| EP0910358A1 (en) * | 1996-05-24 | 1999-04-28 | Neurosearch A/S | Phenyl derivatives useful as blockers of chloride channels |
| WO2010051129A2 (en) * | 2008-10-03 | 2010-05-06 | The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Materiel Command | New imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use |
| CN103917520B (zh) | 2011-10-11 | 2016-08-24 | 基尔梅斯国立大学 | 苯基胍衍生物 |
-
2015
- 2015-08-11 AR ARP150102582A patent/AR101498A1/es not_active Application Discontinuation
-
2016
- 2016-08-10 ES ES16756641T patent/ES2756580T3/es active Active
- 2016-08-10 PL PL16756641T patent/PL3334707T3/pl unknown
- 2016-08-10 CN CN201680045772.4A patent/CN107922322B/zh not_active Expired - Fee Related
- 2016-08-10 SM SM20190747T patent/SMT201900747T1/it unknown
- 2016-08-10 DK DK16756641.3T patent/DK3334707T3/da active
- 2016-08-10 PT PT167566413T patent/PT3334707T/pt unknown
- 2016-08-10 WO PCT/EP2016/069033 patent/WO2017025560A1/en not_active Ceased
- 2016-08-10 MX MX2018001548A patent/MX383481B/es unknown
- 2016-08-10 LT LTEP16756641.3T patent/LT3334707T/lt unknown
- 2016-08-10 RS RS20191669A patent/RS59759B1/sr unknown
- 2016-08-10 SI SI201630561T patent/SI3334707T1/sl unknown
- 2016-08-10 RU RU2018107840A patent/RU2737430C2/ru active
- 2016-08-10 BR BR112018002614-0A patent/BR112018002614B1/pt not_active IP Right Cessation
- 2016-08-10 JP JP2018506997A patent/JP6748188B2/ja not_active Expired - Fee Related
- 2016-08-10 HR HRP20192301TT patent/HRP20192301T1/hr unknown
- 2016-08-10 US US15/751,437 patent/US10343984B2/en active Active
- 2016-08-10 HU HUE16756641A patent/HUE046959T2/hu unknown
- 2016-08-10 CA CA2994781A patent/CA2994781A1/en active Pending
- 2016-08-10 EP EP16756641.3A patent/EP3334707B1/en active Active
-
2019
- 2019-12-27 CY CY20191101359T patent/CY1122481T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3334707B1 (en) | 2019-10-09 |
| RU2018107840A3 (https=) | 2019-12-18 |
| CN107922322B (zh) | 2023-11-03 |
| US10343984B2 (en) | 2019-07-09 |
| CN107922322A (zh) | 2018-04-17 |
| HUE046959T2 (hu) | 2020-04-28 |
| RU2018107840A (ru) | 2019-09-12 |
| BR112018002614B1 (pt) | 2023-04-11 |
| HRP20192301T1 (hr) | 2020-03-20 |
| LT3334707T (lt) | 2020-01-27 |
| DK3334707T3 (da) | 2020-01-06 |
| PL3334707T3 (pl) | 2020-05-18 |
| PT3334707T (pt) | 2020-01-14 |
| SMT201900747T1 (it) | 2020-03-13 |
| US20180244608A1 (en) | 2018-08-30 |
| HK1256253A1 (en) | 2019-09-20 |
| MX383481B (es) | 2025-03-14 |
| JP6748188B2 (ja) | 2020-08-26 |
| SI3334707T1 (sl) | 2020-03-31 |
| RS59759B1 (sr) | 2020-02-28 |
| AR101498A1 (es) | 2016-12-21 |
| JP2018525393A (ja) | 2018-09-06 |
| CA2994781A1 (en) | 2017-02-16 |
| CY1122481T1 (el) | 2021-01-27 |
| MX2018001548A (es) | 2018-06-22 |
| BR112018002614A2 (https=) | 2018-10-02 |
| WO2017025560A1 (en) | 2017-02-16 |
| EP3334707A1 (en) | 2018-06-20 |
| RU2737430C2 (ru) | 2020-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2881395T3 (es) | Composiciones y métodos para inhibir la actividad de la arginasa | |
| ES2975263T3 (es) | Formas cristalinas de un compuesto triazolopirimidínico | |
| ES3061350T3 (en) | Salts and solid form of a btk inhibitor | |
| ES2960953T3 (es) | Forma de sal de clorhidrato para la inhibición de EZH2 | |
| CN107257801B (zh) | 选择性bace1抑制剂 | |
| TWI597282B (zh) | ６，７-不飽合-７-胺甲醯基嗎啡喃衍生物之結晶及其製造方法 | |
| JP5596680B2 (ja) | 経口抗がん製剤 | |
| ES3040587T3 (en) | Fenfluramine compositions and methods of preparing the same | |
| CN103140512B (zh) | 聚合物缀合的MetAP2抑制剂及其应用的治疗方法 | |
| ES2714100T3 (es) | Compuestos de quinolina fusionados como inhibidores de mTor, pi3k | |
| JP7794910B2 (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| ES2347185T3 (es) | Nuevos derivados de imidazoles, su preparacion y su utilizacion como medicamento. | |
| CN106478502B (zh) | 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用 | |
| WO2023061406A1 (zh) | 含三并环结构的parp抑制剂、及其制备方法和医药用途 | |
| CN117203208A (zh) | 靶向活化与失活态kras g12d的抑制剂 | |
| KR20090122218A (ko) | ５-(２,４-디히드록시-５-이소프로필-페닐)-４-(４-모르폴린-４-일메틸-페닐)-이속사졸-３-카르복실산 에틸아미드의 산 부가염, 수화물 및 다형체, 및 이들 형태를 포함하는 제제 | |
| ES2969887T3 (es) | Derivados de ácido sulfopropanoico para tratar trastornos neurodegenerativos | |
| ES2756580T3 (es) | Procedimiento para la preparación del compuesto N-(3,5-dimetilfenil)-N'-(2-trifluorometilfenil) guanidina | |
| ES2844425T3 (es) | Forma polimórfica cristalina de 3-hidroxi-4,5-bis-benciloxi-6-benciloximetil-2-fenil-2-oxo-2lambda5-[1,2]oxafosfinano | |
| WO2022063197A1 (zh) | 一种嘧啶甲酰胺类化合物及其应用 | |
| TW201922690A (zh) | 環－amp反應元素結合蛋白的抑制劑 | |
| JP2025509950A (ja) | Ｐｉ３ｋ阻害剤の結晶形態及び塩ならびにその製造方法及びその使用方法 | |
| HK1256253B (en) | A process for the preparation of the compound n-(3,5-dimethylphenyl)-n'-(2-trifluoromethylphenyl) guanidine | |
| RU2802964C2 (ru) | Твердые формы 2-(5-(4-(2-морфолиноэтокси)фенил)пиридин-2-ил)-n-бензилацетамида | |
| ES2354286T3 (es) | Cristal de un compuesto de indol que contiene sulfonamida y procedimiento de producción del mismo. |